Outset Medical, Inc. reaffirmed its previously provided guidance for 2024, including revenue of $145 million to $153 million, growing 12% to 18% over 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.635 USD | +3.86% | -11.50% | -32.44% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.44% | 181M | |
+12.99% | 227B | |
+13.76% | 192B | |
+17.12% | 136B | |
+28.28% | 108B | |
+1.67% | 64.07B | |
+17.45% | 52.1B | |
+7.04% | 51.87B | |
+10.62% | 44.33B | |
+5.23% | 36.75B |
- Stock Market
- Equities
- OM Stock
- News Outset Medical, Inc.
- Outset Medical, Inc. Reaffirms Earnings Guidance for 2024